DAIC

JANUARY 23, 2024

a leader in non-invasive artificial intelligence (AI) precision coronary solutions, announced FFRCT was transitioned to a Category I Current Procedural Terminology (CPT) code beginning January 1, 2024. milla1cf Tue, 01/23/2024 - 13:44 January 23, 2024 — HeartFlow, Inc. ,

Reimbursement 105

Reimbursement Coronary Artery Disease CMS Technology 105

DAIC

MARCH 1, 2024

Food and Drug Administration ( FDA ) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. Boston Scientific plans to launch the technology in the U.S. vs. 28.7%; P=0.006). in the coming months.

Stents 105

Stents Stent Coronary Artery Disease Angioplasty 105

DAIC

JANUARY 17, 2024

With the continuous progress of science and technology, artificial intelligence (AI) has become an important driving force for a new round of scientific and technological revolution and industrial change. In recent years, the attempts of AI to run through the whole process of CCTA have expanded the application scope of CCTA.

Technology 111

Technology Coronary Artery Disease Cardiovascular Disease Cardiovascular Imaging 111

DAIC

APRIL 12, 2024

a pioneering medical technology company specializing in cardiovascular interventional devices, today announced that its groundbreaking Acolyte Image Guided Crossing and Re-Entry Catheter System has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ).

Technology 111

Technology Cardiovascular Interventions Coronary Artery Disease Innovation 111

DAIC

JANUARY 3, 2024

6 Also in 2023, HeartFlow released its RoadMap Analysis which helps identify and quantify narrowings in the coronary arteries and has demonstrated a 25% faster CCTA read time. HeartFlow is committed to serving customers quickly and reliably with a median turnaround time less than 1.5

Coronary Artery Disease 59

Coronary Artery Disease Chest Pain Plaque Technology 59

DAIC

DECEMBER 19, 2023

The scanner combines the power and speed of dual-source CT technology—two X-ray tubes and two detectors—with embedded artificial intelligence and user assistance features to deliver workflow efficiencies. The optional FAST ( Fully Assisting Scanner Technologies ) 3D camera automatically performs precise, consistent patient positioning.

Chest Pain 104

Chest Pain Coronary Artery Disease Technology Outpatient 104

DAIC

MARCH 20, 2024

CLTI is the most severe form of peripheral arterial disease (PAD), estimated to affect 11% of the 200 million people suffering from PAD globally. degradation of magnesium observed 12 months after implantation in coronary arteries.4 2,3 It has shown 99.6% Jörg Pochert, President of Vascular Intervention at Biotronik.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Innovation Technology Coronary Artery Disease 105

DAIC

MARCH 6, 2024

milla1cf Wed, 03/06/2024 - 18:48 March 6, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ) for its Coronary Artery Disease ( CAD ) Staging System.

Heart Disease 105

Heart Disease Heart attacks Heart Attack Technology 105

DAIC

JUNE 27, 2024

Attendees can join with their peers and participate in sessions on structural heart disease, congenital heart disease, guidelines and trials, AI/Machine learning, technical aspects of cardiac CT, coronary artery disease, vascular heart disease, debates and games and early career topics. for all attendees.

Congenital Heart Disease 105

Congenital Heart Disease Coronary Artery Disease Congenital Heart Disease 105

DAIC

JULY 31, 2024

In its announcement about the workbook, ACC noted that cardiologists use digital devices and wearable technology to remotely monitor their patients for a variety of chronic cardiovascular diseases, including heart failure, coronary artery disease, vascular disease and atrial fibrillation.

Reimbursement 98

Reimbursement Technology Coronary Artery Disease Best Practices 98

DAIC

JUNE 25, 2024

milla1cf Tue, 06/25/2024 - 18:58 June 25, 2024 — Nano-X Imaging (Nanox), an innovative medical imaging technology company, today announced that data from five studies supporting the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox AI, will be presented at the 19th Annual Meeting of the Society of Cardiovascular Computed Tomography ( SCCT (..)

Coronary Artery Disease 105

Coronary Artery Disease Hospital Innovation Technology 105

DAIC

JANUARY 15, 2024

FDA Breakthrough Device Designation recognizes novel innovations that demonstrate the potential to provide more effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases.

Ultrasound 119

Ultrasound Coronary Artery Disease Innovation Heart Failure 119

DAIC

JANUARY 8, 2024

Recognizing the industry transformation taking place as digital innovation reshapes the experience of patients and providers, GE HealthCare – a leading global medical technology, pharmaceutical diagnostics, and digital innovator – is focused on developing smart devices, aligned to disease states and enabled by digital.

Innovation 105

Innovation Technology Patient Care Coronary Artery Disease 105

DAIC

JULY 25, 2024

mtaschetta-millane Thu, 07/25/2024 - 08:55 July 25, 2024 — Nanox, an innovative medical imaging technology company, announced that the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox.AI was highlighted in multiple scientific presentations at the 2024 Society of Cardiovascular Computed Tomography (SCCT) Annual Meeting. “We

Innovation 105

Innovation Coronary Artery Disease Hospital Cardiovascular Disease 105

DAIC

MARCH 28, 2024

milla1cf Thu, 03/28/2024 - 07:00 March 28, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, shared findings from a study published online in the Journal of the American College of Cardiology: Cardiovascular Imaging on March 13, 2024.

Ischemia 110

Ischemia Chest Pain Atherosclerosis Coronary Artery Disease 110

AMS Cardiology

MARCH 31, 2025

Coronary Artery Disease : Blocked arteries can affect heart function and rhythm. We offer comprehensive care plans tailored to each patient’s unique needs, utilizing the latest advancements in medical technology and treatment strategies.

Atrial Fibrillation 52

Atrial Fibrillation AFIB Heart Rhythm Blood Pressure 52

Clinical Trial Results

NOVEMBER 13, 2023

Disclosures: TBD

Coronary Artery Disease 40

Coronary Artery Disease Risk Factors Technology 40

Cardiometabolic Health Congress

AUGUST 2, 2024

The Omics Revolution: Powering Precision Nutrition Omics technologies form the backbone of genetically tailored nutrition, providing unprecedented insights into the molecular intricacies of human biology: Genomics : Unraveling the DNA blueprint to identify genetic variations that influence nutrient metabolism and dietary responses.

Diet 59

Diet Technology Coronary Artery Disease Quality of Life 59

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Introduction The use of contemporary drug-eluting stents (DES) has significantly improved outcomes of patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI).

Stents 64

Stents Stent Cardiogenic Shock Coronary Artery Disease 64

Open Heart

JUNE 22, 2023

Objective Since inception CT coronary angiography (CTCA) has required facilitating beta blockers (BB). However, CT technology has improved rapidly as has radiographer and reporter expertise. Using these factors, we instituted a radiographer led cardiac CT service (RLCCTS), without routine BB, which we studied for quality control (QC).

Chest Pain 52

Chest Pain Coronary Artery Disease Technology Hospital 52

Heart BMJ

JANUARY 29, 2024

Assessment of patients presenting for the first time with suspected coronary artery disease (CAD) remains cumbersome with multiple diagnostic options. 1 2 The steady thump of patients’ feet on the treadmill has instead been replaced by scanner-based technologies.

Exercise 40

Exercise Chest Pain Coronary Artery Disease Angina 40

DAIC

OCTOBER 16, 2024

Members of the Society of Cardiovascular Computed Tomography (SCCT) Health Policy & Practice Committee (HPPC) presented as subject matter experts during a May 2023 MAC-led Multijurisdictional Meeting on CAC Non-Invasive Technology for Coronary Artery Plaque Analysis and later provided comments on the draft LCDs that helped shape the final policies.

CMS 52

CMS Medicare Plaque Chest Pain 52

Wellnest

JUNE 19, 2023

By harnessing the power of the latest technology, healthcare providers can enhance diagnostics, treatment planning, and patient care. The latest technology utilizes the existing data of an Artificial Neural network (ANN). Novel technology is also proving to be better than traditional conventional ECG machines.

Technology 52

Technology Cardiac Arrest Innovation Coronary Artery Disease 52

GEMMS

AUGUST 29, 2024

These technologies are not just reshaping but also empowering how cardiology practices manage operations, deliver care, and enhance patient outcomes. These technologies are reshaping how cardiology practices manage operations, deliver care, and enhance patient outcomes.

Technology 52

Technology Patient Care Outcomes Coronary Artery Disease 52

DAIC

OCTOBER 16, 2024

16, 2024 — Sahajanand Medical Technologies (SMT) recently announced the publication of the COMPARE 60/80 HBR trial results in Circulation: Cardiovascular Interventions , a journal of The American Heart Association. tim.hodson Wed, 10/16/2024 - 09:00 Oct. Led by Dr. Pieter C. Principal Investigator, Dr. Pieter C.

Stents 52

Stents Stent Thrombosis Coronary Artery Disease 52

ADN Center of Excellence

OCTOBER 7, 2024

Interventional cardiology has dramatically evolved over the past decades, introducing advanced techniques and tools that have revolutionized the treatment of coronary artery disease, valvular disorders, and structural heart diseases.

Interventional Cardiology 59

Interventional Cardiology Coronary Artery Disease Innovation Anatomy 59

DAIC

MARCH 11, 2024

A prospective multi-center clinical study of the device is scheduled to begin enrollment this year. “We have many interventional or surgical revascularization options for patients with advanced large coronary artery disease. However, a significant proportion still suffer from angina. VahatiCor, Inc.,

Angina 59

Angina Innovation Heart Disease Chest Pain 59

ADN Center of Excellence

OCTOBER 7, 2024

Interventional cardiology has dramatically evolved over the past decades, introducing advanced techniques and tools that have revolutionized the treatment of coronary artery disease, valvular disorders, and structural heart diseases.

Interventional Cardiology 52

Interventional Cardiology Coronary Artery Disease Innovation Anatomy 52

Dr. Paddy Barrett

AUGUST 22, 2023

Subscribe now APOE4 & Cardiovascular Risk We now know that carriers of APOE4 typically have higher circulating APOB levels, but the question is how much this influences the risk of cardiovascular disease. The association of apolipoprotein-E ( APOE ) gene polymorphisms with coronary artery disease: a systematic review and meta-analysis.

Cholesterol 52

Cholesterol Dementia Cardiovascular Disease Coronary Artery Disease 52

DAIC

MAY 14, 2024

Together, the two companies will work to further the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to the assessment of coronary physiology, as part of GE HealthCare’s interventional cardiology portfolio built around the Allia Platform.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

Dr. Paddy Barrett

SEPTEMBER 19, 2023

They are also at an increased risk of coronary artery disease (Discussed in more detail here ). 9 Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology. This one requires some nuance. 2022 Sep 10;400(10355):832-845. J Lipid Res. 2012 Mar;53(3):567-576.

Dementia 52

Dementia Cholesterol Biomarkers Coronary Artery Disease 52

Frontiers in Cardiovascular Medicine

MARCH 7, 2024

The 2017 World Health Organization Fact Sheet highlights that coronary artery disease is the leading cause of death globally, responsible for approximately 30% of all deaths. In this context, machine learning (ML) technology is crucial in identifying coronary artery disease, thereby saving lives.

Coronary Artery Disease 111

Coronary Artery Disease Biomarkers Technology Outcomes 111

DAIC

MARCH 27, 2024

a leader in AI-driven healthcare technology, announced the launch of the DECIDE Registry, the largest prospective registry of its kind, with the first site initiated, Cone Health Care. Coronary artery disease remains one of the leading causes of death in the United States.

Coronary Artery Disease 111

Coronary Artery Disease Plaque Technology Anatomy 111

DAIC

MARCH 28, 2025

v As cardiovascular disease (CVD) continues to rise globally, vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. CCTA offers a non-invasive, cost-effective, and highly sensitive method for diagnosing coronary artery disease (CAD), making it a valuable tool for clinicians.

Technology 59

Technology Coronary Artery Disease Medicare Atrial Fibrillation 59

DAIC

FEBRUARY 26, 2025

a provider of AI technology for coronary artery disease (CAD) management, recently introduced its new brand identity reflecting its focus on delivering clarity, precision and confidence in the prevention, diagnosisand treatment of CAD. References Centers for Disease Control and Prevention. Heart Disease Facts.

Coronary Artery Disease 59

Coronary Artery Disease Heart attacks Heart Attack Technology 59

DAIC

DECEMBER 5, 2024

Cleerly is dedicated to creating a new standard of care for heart disease by using FDA-cleared solutions powered by artificial intelligence. Cleerly’s pioneering approach to advanced cardiovascular imaging, powered by AI-driven analysis, is elevating the field of diagnostic tools for coronary artery disease.

Coronary Artery Disease 52

Coronary Artery Disease Medicare Plaque Technology 52

DAIC

MAY 8, 2024

1 Atherosclerosis is a systemic disease that affects multiple vascular regions and is particularly severe in PAD patients, where up to 80 percent suffer from concurrent coronary artery disease (CAD), historically linked with a mortality rate exceeding 50 percent within five years.

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction 111